Clinical Trials Logo
  1. Home
  2. Fuchs' Endothelial Dystrophy
  3. NCT04018417

Evaluation of Amphotericin B in Optisol-GS for Prevention of Post-Keratoplasty Fungal Infections.

Fuchs' Endothelial Dystrophy Clinical Trial

Official title:
A Randomized, Double-masked, Placebo-controlled Study of the Safety of Amphotericin 0.255 μg/mL in Optisol-GS

Clinical Trial Summary

With the increasing popularity of endothelial keratoplasty, a coincident increase in the rate of fungal infections post-keratoplasty has been seen in the United States. In this study, the eye bank will harvest pairs of donor corneas and randomize one cornea from each pair to be stored in Optisol-GS per Eye Bank Association of America guidelines. The eye bank will add amphotericin B 0.255 μg/mL (antifungal) to the storage solution for the mate cornea. The study donor corneas will be assigned to participants who are scheduled to undergo Descemet membrane endothelial keratoplasty. The surgeons, participants, and evaluators will remain masked regarding the donor cornea storage solution assignment. The participants will be followed for 6 months.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04018417
Study type Interventional
Source Cornea Research Foundation of America
Contact
Status Withdrawn
Phase Phase 2/Phase 3
Start date July 3, 2019
Completion date July 3, 2019
View Details
See also
  Status Clinical Trial Phase
Completed NCT03248037 - Trial of Netarsudil for Prevention of Corticosteroid-induced Intraocular Pressure Elevation Phase 3
Recruiting NCT03275896 - Evaluation of the Efficacy of Descemet Membrane Transplantation for the Treatment of Fuchs' Endothelial Dystrophy Early Phase 1
Completed NCT02332109 - ODM 5 in the Treatment of Corneal Edematous Fuchs' Endothelial Dystrophy N/A
Completed NCT02470793 - Technique And Results In Endothelial Keratoplasty N/A
Recruiting NCT01206127 - DSAEK- Postoperative Positioning and Transplant Dislocation N/A
Recruiting NCT03407755 - Air Versus SF6 for Descemet's Membrane Endothelial Keratoplasty (DMEK) N/A
Completed NCT04140422 - Eye Drops for Early Morning-Associated Corneal Swelling of the Cornea N/A
Recruiting NCT06048380 - The Effects of Ripasudil in Patients With FED Undergoing Femtosecond Laser Assisted Cataract Surgery Phase 3
Completed NCT02793310 - DMEK Versus DSAEK Study N/A
Completed NCT01795001 - The Molecular Pathogenesis of Late-onset Fuchs' Endothelial Corneal Dystrophy
Completed NCT04057053 - Netarsudil Use After Descemetorhexis Without Endothelial Keratoplasty Early Phase 1
Terminated NCT01361282 - Using the Optovue OCT to Select IOL Power N/A
Completed NCT02542644 - Assessment of Corneal Graft Attachment in Patients With Fuchs Endothelial Corneal Dystrophy Following DMEK Using Ultra-high Resolution OCT N/A
Recruiting NCT04191629 - Phase 1 Study to Evaluate the Safety and Tolerability of EO1404 in the Treatment of Corneal Edema Phase 1
Completed NCT05399095 - Supine Positioning for Graft Attachment After Descemet Membrane Endothelial Keratoplasty N/A
Not yet recruiting NCT06261346 - Plasma Rich in Growth Factors in Corneal Endothelial Transplantation N/A
Completed NCT04752020 - Netarsudil Use After Descemtorhexis Without Endothelial Keratoplasty Early Phase 1
Not yet recruiting NCT05716945 - The OPTIMISE Study Phase 4
Recruiting NCT03575130 - Ripasudil 0.4% Eye Drops in Fuchs Endothelial Corneal Dystrophy Phase 2
Recruiting NCT02118922 - A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia